Wendy A. Davis

University of Western Australia

H指数:56

被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Refining insights on type 2 diabetes and aortic valve replacement-reply to Liu et al.

对2型糖尿病和主动脉瓣置换术的见解的提炼——回复给刘等人

Diabetic Medicine

IF3.4

2026-02-010

PRE

Prognostic value of a plasma protein-based biomarker test for chronic kidney disease complicating diabetes in Aboriginal Australians

糖尿病合并慢性肾病在澳大利亚原住民中血浆蛋白基生物标志物检测的预后价值

Internal Medicine Journal

IF1.5

2025-12-010

PRE

The relationship between shrunken pore syndrome/selective glomerular hypofiltration syndromes and all-cause mortality in the Fremantle Diabetes Study Phase II. Reply to Gu X, Wei Y [letter]

缩窄性孔道综合征/选择性肾小球低滤过综合征与弗莱芒特糖尿病研究第二阶段的全因死亡率之间的关系。回复：Gu X，Wei Y[来信]

Diabetologia

IF10.2

2025-09-040

PRE

Effects of subclinical hypothyroidism on nephropathy complicating type 2 diabetes: The Fremantle Diabetes Study Phase II

亚临床甲状腺功能减退症对合并肾病的2型糖尿病的影响：弗莱芒顿糖尿病研究第二阶段

The Journal of Clinical Endocrinology & Metabolism

IF0

2025-08-290

OAAI

Characteristics of Dyslipidemia in Adults With Resistance to Thyroid Hormone β

成人甲状腺激素β抵抗患者的血脂异常特征

Endocrine Practice

IF4.6

2025-07-050

PRE

The relationship between shrunken pore syndrome and all-cause mortality in people with type 2 diabetes and normal renal function: the Fremantle Diabetes Study Phase II

缩窄孔综合征与2型糖尿病伴正常肾功能人群的全因死亡率关系：弗莱明汉糖尿病研究第二阶段

DIABETOLOGIA

IF10.2

2025-04-210

Clinical Features and Implications of Albuminuria Trajectories in Type 2 Diabetes: The Fremantle Diabetes Study Phase 2

2型糖尿病中白蛋白尿轨迹的临床特征与意义：Fremantle糖尿病研究第2阶段

JOURNAL OF THE ENDOCRINE SOCIETY

IF3.1

2025-04-080

PromarkerD Versus Standard of Care Biochemical Measures for Assessing Future Renal Function Decline in Type 2 Diabetes

DIAGNOSTICS

IF3.3

2025-03-090

OAAI

Cardiovascular Risk and Plasma N-terminal Pro-B-type Natriuretic Peptide in Adults With Resistance to Thyroid Hormone β

JOURNAL OF THE ENDOCRINE SOCIETY

IF3.1

2025-02-110

OAAI

The relationship between serum HDL-cholesterol, cardiovascular disease and mortality in community-based people with type 2 diabetes: the Fremantle Diabetes Study phase 2

CARDIOVASCULAR DIABETOLOGY

IF10.6

2024-10-140

OAAI

Prevalence and prognostic significance of cardiac autonomic neuropathy in community-based people with type 2 diabetes: the Fremantle Diabetes Study Phase II

社区2型糖尿病患者心脏自主神经病变的患病率和预后意义: Fremantle糖尿病II期研究

CARDIOVASCULAR DIABETOLOGY

IF10.6

2024-03-182

OAAI

Pulmonary Function Trajectories Over 6 Years and Their Determinants in Type 2 Diabetes: The Fremantle Diabetes Study Phase II

DIABETES CARE

IF16.6

2024-01-112

The Clinical Relevance of Diabetes Distress versus Major Depression in Type 2 Diabetes: A Latent Class Analysis from the Fremantle Diabetes Study Phase II

JOURNAL OF CLINICAL MEDICINE

IF2.9

2023-12-160

OAAI

The Relationship between Pulmonary Artery Pressure and Mortality in Type 2 Diabetes: A Fremantle Diabetes Study Phase II and National Echocardiographic Database of Australia Data Linkage Study

JOURNAL OF CLINICAL MEDICINE

IF2.9

2023-12-140

OAAI

An assessment of factors contributing to the decline in risk of stroke complicating type 2 diabetes: The Fremantle Diabetes Study

DIABETES OBESITY & METABOLISM

IF5.7

2023-12-110

Temporal Trends in Distal Symmetric Polyneuropathy in Type 2 Diabetes: The Fremantle Diabetes Study

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

IF5.1

2023-11-012

The relationship between glycated haemoglobin and blood glucose-lowering treatment trajectories in type 2 diabetes: The Fremantle Diabetes Study Phase II

DIABETES OBESITY & METABOLISM

IF5.7

2023-10-050

The effect of empagliflozin and fenofibrate therapies, alone and in combination, on the serum urate concentration in hyperuricaemic type 2 diabetes

DIABETES OBESITY & METABOLISM

IF5.7

2023-09-192

Temporal trends in chronic complications of diabetes by sex in community-based people with type 2 diabetes: the Fremantle Diabetes Study

CARDIOVASCULAR DIABETOLOGY

IF10.6

2023-09-161

OAAI

Comparative mortality and its determinants in community-based people with type 1 diabetes: the Fremantle Diabetes Study Phase I

BMJ OPEN DIABETES RESEARCH & CARE

IF4.1

2023-07-241

OAAI

Wendy A. Davis

个人简介

教育背景

工作经历

荣誉奖项

研究方向